From January 9, 2023 to March 31, 2023, the company has repurchased 12,096,900 shares, representing 0.87% for CNY 100.01 million. With this, the company has completed the repurchase of 12,096,900 shares, representing 0.87% for CNY 100.01 million under the buyback announced on January 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.57 CNY | +0.28% | +0.28% | -55.98% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-55.98% | 677M | |
+41.52% | 6.2B | |
-23.06% | 4.09B | |
+11.98% | 3.48B | |
-19.68% | 2.82B | |
-11.52% | 2.28B | |
+45.53% | 1.94B | |
-8.31% | 1.51B | |
+48.41% | 1.53B | |
-19.16% | 1.47B |
- Stock Market
- Equities
- 002424 Stock
- News Guizhou Bailing Group Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.